高位硬脊膜外腔阻滞治疗难治性心力衰竭疗效观察  

Effect of thoracic epidual analgesia to treat obstinate heart failure

作　　者：李玉梅[1] 陈文东[2] 

机构地区：[1]温州市中医院ICU,浙江温州325000 [2]温州市中医院麻醉科,浙江温州325000

出　　处：《临床心血管病杂志》2005年第10期580-581,共2页Journal of Clinical Cardiology

摘　　要：目的:观察高位硬脊膜外腔阻滞(TEA)治疗难治性心力衰竭的治疗效果及不良反应.方法:取胸椎4～5间隙为穿刺点,每6～8 h推注0.25%罗哌卡因注射液5～7 ml,共用4周,监测血压、心率、心电图、心胸比、左室舒张末期内径、左室射血分数、不良反应等.结果:TEA治疗难治性心力衰竭10例,总有效率90%,治疗后心率、血压均较前明显下降,心功能较前明显改善,心律失常明显减少,差异均有统计学意义(均P＜0.05).结论:TEA治疗难治性心力衰竭安全、有效,其远期疗效有待于进一步观察.Objective：Ropivacaine was used for thoracic epidual analgesia（TEA）, to treat obstinate heart fail ure by coronary heart disease,and the therapeutic effects and side effects were observed. Method： A total of 10 patients were injected 0.25% ropivacaine （5-7 ml per six to eight hours） for four weeks. Observing blood pres sure, heart rate ,cardiac enzymes and electrocardiograms, the ratio of heart size to chest size, the left ventricular end diastolic diameter, ejection fraction and side effect et. Result：Ten patients obstinate heart failure by coronary heart disease were treated by TEA, the successful hemostasis rate was 90 %. After treatment , heart rate and blood pressure obviously decreased , cardiac function significantly increased,cardiac arrhythmia obviously reduced （ P 〈0.05）. Conclusion：It is safe and effective to use ropivacaine to treat obstinate heart failure by coronary heart disease. Following up study should be paid in order to ascertain the long-term effect.

关 键 词：心力衰竭 高位硬膜外阻滞 罗哌卡因 

分 类 号：R541.6[医药卫生—心血管疾病]